explore -WSS

explore

author：knowledge 2025-10-01 17:20:07 - browse：9751

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Bright Health sells Medicare Advantage business to Molina

WSS

Duchenne breakthrough therapy leaves behind pioneering families

Couple fighting to bring baby home from Mexico are finally reunited

Trump demands the U.S. pay no more for drugs than other countries … again

Sports medicine is finally prioritizing gender equality

Trump demands the U.S. pay no more for drugs than other countries … again

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

focus

explore

explore

Drug repurposing or repositioning? The language matters

Medical leaders decry Supreme Court decision on affirmative action

Novavax promises a turnaround & Lilly roils the obesity market

DOJ, FTC to increase scrutiny of all types of health care mergers

The high cost of giving birth even with insurance

New warning issued for rebooking air travel after delays, cancellations

Continuity nursing helped my family in our darkest PICU moments

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Peter Hotez and the public health issue of online harassment

Alkermes shareholders re

knowledge

New air purifier tech could be key to improving indoor air quality

Psychedelics group wrestles with new pharma identity

23andMe had bad news about my health. I wish a person had delivered it

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Trump got a 'target letter.' What is one and what does it mean?

focus

hotspot

entertainment

knowledge